Erratum
Unfortunately, the original version of this article [1] did not include any funding information in the “Acknowledgements” section. The complete “Acknowledgements” section is included in full in this erratum.
Acknowledgements
The authors acknowledge the contribution of all investigators at all participating study sites. We thank Dr. Ju-Hong Yang, Metabolic Disease Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University (Tianjin, People’s Republic of China), for expert technical assistance with statistical analysis. This study was supported by grants from the National Natural Science Foundation of China (No. 81272401), the International Foundation of Translational Medicine for Abroad Scholars and Students, U.S. and China (No.UCTMP2015-03C001), the Foundation of Shanghai Health Bureau, Shanghai, PR China (No. 2012QJ001A). Z.C. acknowledges the support from the Society in Science-Branco Weiss fellowship administered by ETH Zürich and National Institute of Health/National Cancer Institute (Grant number 1U01CA202123-01, Subaward number 113098–5093073).
Footnotes
The online version of the original article can be found under doi:10.1186/s13046-016-0361-8.
Contributor Information
Xiu-Yan Huang, Email: xyhuang1119@163.com.
Xin-Yu Huang, Email: xinyuhuang9@163.com.
Reference
- 1.Huang XY, Huang ZL, Xu B, Chen Z, Re TJ, Zheng Q, Tang ZY, Huang XY. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35(1):85. doi: 10.1186/s13046-016-0361-8. [DOI] [PMC free article] [PubMed] [Google Scholar]